SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-124264
Filing Date
2021-10-08
Accepted
2021-10-07 18:24:50
Documents
2
Group Members
MARK ANGELOYA GLOBAL II SPV, LLCYA GLOBAL INVESTMENTS II (U.S.), LPYAII GP II, LLCYAII GP, LPYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2129554d1_sc13g.htm SC 13G 127821
2 EXHIBIT 99.1 tm2129554d1_ex99-1.htm EX-99.1 14798
  Complete submission text file 0001104659-21-124264.txt   144519
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92065 | Film No.: 211313364
SIC: 2834 Pharmaceutical Preparations